Zepp Health Corporation, listed on the New York Stock Exchange as ZEPP, has reported a strong financial performance for the first quarter of 2026, projecting revenues between $50 million and $55 million, which represents a year-over-year increase of 30% to 43%. This growth is attributed to the company's successful transition from a traditional hardware manufacturer to a hybrid training platform, focusing on premium products and leveraging AI-driven insights. In 2025, Zepp's total revenue reached $259 million, a 41.8% increase from the previous year, with Q4 revenue growth of 43%. The company achieved a record gross margin of 40.4% in Q4, driven by a favorable product mix and strategic brand positioning. Looking ahead, Zepp Health plans to continue expanding its premium product lineup and enhancing its ecosystem through strategic partnerships, including collaborations with elite athletes and endurance events. The company is also committed to maintaining a strong balance sheet with a cash position of $113 million and aims to reduce operating expenses in 2026.